Oracle and Ci4CC Partner to Accelerate Oncology Innovation

Core Insights - The collaboration between Oracle Health and Life Sciences and the Cancer Center Informatics Society (Ci4CC) aims to advance AI innovation in oncology care and research [1][2] - The partnership will focus on designing an EHR optimized for cancer care, integrating clinical and genomic data for personalized medicine, and pioneering AI-driven approaches for clinical trial innovation [2][3] Collaboration Details - The strategic collaboration combines Oracle's technology with Ci4CC's national network of NCI-Designated and Community Care Cancer Centers [2] - The initiative will include establishing robust real-world evidence frameworks and advancing precision oncology platforms [2][4] Leadership Statements - Seema Verma from Oracle emphasized the potential of AI and data science in combating cancer, highlighting the opportunity to accelerate discoveries [2] - Sorena Nadaf-Rahrov from Ci4CC noted that advancements in cancer research require collaborative networks, which is central to their mission [3][4] Operational Goals - The collaboration aims to turn data into actionable knowledge to improve cancer research and patient care [4] - The agreement is non-binding, indicating a flexible approach to the partnership [4]